265 Church Street, 14th Floor
New Haven, CT 06510
Phone: 203-687-4422
Fax: 475-202-6844
PLEASE BE ADVISED OF THE IMPORTANT UPDATE BELOW


March 17, 2020
 


Re:        COVID-19 Update
__________________________________________________________________

Dear CMG Providers,


Essential updates for today:





  • Today, The Trump Administration announced expanded Medicare telehealth coverage that will enable beneficiaries to receive a broader range of healthcare services from their doctors without having to travel to a healthcare facility. Beginning on March 6, 2020, Medicare will temporarily pay clinicians to provide telehealth services for beneficiaries residing across the entire country.
  • To read the Fact Sheet on this announcement, click here.
  • To read the Frequently Asked Questions on this announcement, click here.

  • For additional information on the list of Medicare telehealth services eligible for reimbursement, please see CCHP’s Fact Sheet on the Finalized CY 2020 Physician Fee Schedule and publication issued by the Centers for Medicare and Medicaid Services (CMS) regarding Medicare coverage and payment related to COVID-19.
 
  • CMS has developed two Healthcare Common Procedure Coding System (HCPCS) codes that can be used by laboratories to bill for specific COVID-19 diagnostic tests to help increase testing and track new cases. Effective for dates of service March 18, 2020, and forward, laboratory providers must use one of the HCPCS codes listed in the bulletin (DSS PB 2020-12) for the billing of COVID-19 diagnostic tests. Reimbursement for the tests will be set at the Medicare rate, and the Laboratory fee schedule will be updated accordingly.
 
  • Please see the Bulletins (2020-09 and 2020-10) that were recently issued by DSS concerning New Coverage of Specified Telemedicine Services Under the Connecticut Medical Assistance Program, and COVID-19 Response on Emergency Temporary Telemedicine Coverage.
 
  • The Connecticut Insurance Department recently issued Bulletin No. IC-39 to all health insurance companies and health care centers authorized to conduct business in Connecticut regarding COVID-19 outbreak and testing.
 
  • HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT (HIPAA): Effective immediately, the HHS Office for Civil Rights (OCR) will exercise enforcement discretion and waive penalties for HIPAA violations against health care providers that serve patients in good faith through everyday communications technologies, such as FaceTime or Skype, during the COVID-19 nationwide public health emergency. For more information click here.


Please forward me any useful information you have, any corrections or updates to the above.

Be safe.


Best,


Joseph L. Quaranta, MD


Joseph L. Quaranta, MD
President, Community Medical Group